𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck

✍ Scribed by Hongping Yu; Yu-jing Huang; Zhensheng Liu; Li-E Wang; Guojun Li; Erich M. Sturgis; David G. Johnson; Qingyi Wei

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
422 KB
Volume
50
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Both p53 tumor suppressor and murine double minute 2 (MDM2) oncoprotein are crucial in carcinogenesis. We hypothesized that MDM2 promoter single nucleotide polymorphisms (SNPs) SNP309 T > G, A2164G, and p53 codon 72 are associated with risk and age at onset of squamous cell carcinoma of head and neck (SCCHN). We genotyped these SNPs in a study of 1,083 Caucasian SCCHN cases and 1,090 cancer‐free controls. Although none of these SNPs individually had a significant effect on risk of SCCHN, nor did their combined putative risk genotypes (i.e., MDM2 SNP309 GT + GG, 2164 AA, and p53 codon 72 CC), we found that individuals with two to three risk genotypes had significantly increased risk of non‐oropharyngeal cancer (OR = 1.42; 95% CI = 1.07–1.88). This increased risk was more pronounced among young subjects, men, smokers, and drinkers. In addition, female patients carrying the MDM2 SNP309 GT and GG genotypes showed a 3‐yr (56.7 yr) and 9‐yr (51.2 yr) earlier age at onset of non‐oropharyngeal cancer (P~trend~ = 0.007), respectively, compared with those carrying the TT genotype (60.1 yr). The youngest age (42.5 yr) at onset of non‐oropharyngeal cancer was observed in female patients with the combined MDM2 SNP309 GG and p53 codon 72 CC genotypes. The findings suggest that MDM2 SNP309, A2164G, and p53 codon 72 SNPs may collectively contribute to non‐oropharyngeal cancer risk and that MDM2 SNP309 individually or in combination with p53 codon 72 may accelerate the development of non‐oropharyngeal cancer in women. Further studies with large sample sizes are warranted to validate these results. © 2011 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

p53 Codon 72 polymorphism and the risk o
p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma
✍ Wenjun Yang; Yanyan Zhang; Xiuyun Tian; Tao Ning; Yang Ke 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract The polymorphisms of the tumor suppressor gene p53 have been extensively investigated in numerous malignant tumors, particularly carcinomas associated with human papillomavirus (HPV) infection. However, the results remain controversial. To address a potential correlation between the p53

p53 codon 72 polymorphisms in human papi
p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx
✍ Federica Perrone; Luigi Mariani; Elisa Pastore; Marta Orsenigo; Simona Suardi; B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract ## BACKGROUND. Tobacco smoking, alcohol abuse, and high‐risk human papillomavirus (HPV) are risk factors in the etiology of oropharyngeal squamous cell carcinomas (SCCs). The __TP53__ polymorphism, in which an arginine (R) is changed to proline (P) at codon 72, is functionally signific

Prevalence of high-risk human papilloma
Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (oscc) patients of Eastern India
✍ Jatin K. Nagpal; Srinivas Patnaik; Bibhu R. Das 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB 👁 1 views

## Abstract Human papillomavirus (HPV) infects the squamous epithelial cells of oral cavity and cervix leading to formation of warts that develops into the cancer. Human papillomavirus (HPV)‐16 and 18 encode E6 oncoprotein, which binds to and induces degradation of the tumour suppressor protein p53